| Mucormycosis–from the pathogens to the disease U Binder, E Maurer, C Lass‐Flörl Clinical Microbiology and Infection 20, 60-66, 2014 | 232 | 2014 |
| The Penicillium chrysogenum antifungal protein PAF, a promising tool for the development of new antifungal therapies and fungal cell biology studies F Marx, U Binder, E Leiter, I Pócsi Cellular and Molecular Life Sciences 65, 445-454, 2008 | 147 | 2008 |
| Functional aspects of the solution structure and dynamics of PAF – a highly‐stable antifungal protein from Penicillium chrysogenum G Batta, T Barna, Z Gaspari, S Sandor, KE Kövér, U Binder, B Sarg, ... The FEBS journal 276 (10), 2875-2890, 2009 | 112 | 2009 |
| Fast-track development of an in vitro 3D lung/immune cell model to study Aspergillus infections P Chandorkar, W Posch, V Zaderer, M Blatzer, M Steger, CG Ammann, ... Scientific reports 7 (1), 11644, 2017 | 81 | 2017 |
| Galleria mellonella: An invertebrate model to study pathogenicity in correctly defined fungal species U Binder, E Maurer, C Lass-Flörl Fungal Biology 120 (2), 288-295, 2016 | 80 | 2016 |
| Galleria mellonella as a host model to study Aspergillus terreus virulence and amphotericin B resistance E Maurer, N Browne, C Surlis, E Jukic, P Moser, K Kavanagh, C Lass-Flörl, ... Virulence 6 (6), 591-598, 2015 | 80 | 2015 |
| The antifungal activity of the Penicillium chrysogenum protein PAF disrupts calcium homeostasis in Neurospora crassa U Binder, M Chu, ND Read, F Marx Eukaryotic Cell 9 (9), 1374-1382, 2010 | 80 | 2010 |
| Epidemiology of invasive fungal infections in the mediterranean area U Binder, C Lass-Flörl Mediterranean journal of hematology and infectious diseases 3 (1), 2011 | 75 | 2011 |
| Galleria mellonella as a model system to study virulence potential of mucormycetes and evaluation of antifungal treatment E Maurer, C Hörtnagl, M Lackner, D Grässle, V Naschberger, P Moser, ... Medical mycology 57 (3), 351-362, 2019 | 70 | 2019 |
| The metalloreductase FreB is involved in adaptation of Aspergillus fumigatus to iron starvation M Blatzer, U Binder, H Haas Fungal Genetics and Biology 48 (11), 1027-1033, 2011 | 67 | 2011 |
| Antifungal drug testing by combining minimal inhibitory concentration testing with target identification by gas chromatography–mass spectrometry C Müller, U Binder, F Bracher, M Giera Nature Protocols 12 (5), 947-963, 2017 | 66 | 2017 |
| The Aspergillus giganteus antifungal protein AFPNN5353activates the cell wall integrity pathway and perturbs calcium homeostasis U Binder, M Bencina, A Eigentler, V Meyer, F Marx BMC microbiology 11, 1-13, 2011 | 63 | 2011 |
| Histidine biosynthesis plays a crucial role in metal homeostasis and virulence of Aspergillus fumigatus AM Dietl, J Amich, S Leal, N Beckmann, U Binder, A Beilhack, E Pearlman, ... Virulence 7 (4), 465-476, 2016 | 62 | 2016 |
| The antifungal protein PAF interferes with PKC/MPK and cAMP/PKA signalling of Aspergillus nidulans U Binder, C Oberparleiter, V Meyer, F Marx Molecular microbiology 75 (2), 294-307, 2010 | 61 | 2010 |
| Blocking Hsp70 enhances the efficiency of amphotericin B treatment against resistant Aspergillus terreus strains M Blatzer, G Blum, E Jukic, W Posch, P Gruber, M Nagl, U Binder, ... Antimicrobial agents and chemotherapy 59 (7), 3778-3788, 2015 | 60 | 2015 |
| Oxidative stress response tips the balance in Aspergillus terreus amphotericin B resistance E Jukic, M Blatzer, W Posch, M Steger, U Binder, C Lass-Flörl, ... Antimicrobial Agents and Chemotherapy 61 (10), 10.1128/aac. 00670-17, 2017 | 49 | 2017 |
| The Zn2Cys6-type transcription factor LeuB cross-links regulation of leucine biosynthesis and iron acquisition in Aspergillus fumigatus N Long, T Orasch, S Zhang, L Gao, X Xu, P Hortschansky, J Ye, F Zhang, ... PLoS Genetics 14 (10), e1007762, 2018 | 41 | 2018 |
| Amphotericin B Resistance in Aspergillus terreus Is Overpowered by Coapplication of Pro-oxidants M Blatzer, E Jukic, W Posch, B Schöpf, U Binder, M Steger, G Blum, ... Antioxidants & redox signaling 23 (18), 1424-1438, 2015 | 39 | 2015 |
| New insights into invasive aspergillosis-from the pathogen to the disease U Binder, C Lass-Florl Current pharmaceutical design 19 (20), 3679-3688, 2013 | 38 | 2013 |
| Etest Cannot Be Recommended for In Vitro Susceptibility Testing of Mucorales R Caramalho, E Maurer, U Binder, R Araújo, S Dolatabadi, C Lass-Flörl, ... Antimicrobial Agents and Chemotherapy 59 (6), 3663-3665, 2015 | 36 | 2015 |
Cornelia Lass-FlörlMedizinische Universität Innsbruck在 i-med.ac.at 的电子邮件经过验证
